Jump to navigation
The Pharmacy and Therapeutics (P&T) Committee is an advisory board established pursuant to Executive Order D004-07. The committee performs clinical reviews of drug classes and makes recommendations which help the Department develop and manage the Medicaid Preferred Drug List (PDL).
The P&T Committee is required to consider clinical criteria such as drug safety and efficacy when making its recommendations. The committee also considers public comments and testimony related to the drug classes being reviewed or other PDL-related agenda items.
Our meeting has a new location: 303 E. 17th Ave, 7th Floor Conference Room, 7ABC, Denver, Colorado 80203
1:00 p.m. - 5:00 p.m.
The Board meets once quarterly in January, April, July, and October
***11th Floor Conference Room, 11ABC***
Our meeting has a standing location: 303 E. 17th Ave, 11th Floor Conference Room, Denver, Colorado 80203
The P&T Committee consists of 7 physicians, 4 pharmacists and 2 client representatives, who are appointed by the Department's Executive Director. Review the Policies and Procedures Manual for more information on the committee's membership, duties and policies.
January 2018 - December 2019 Term
Lynn Parry, MD (Chairperson)
Patricia M. Lanius, RPh (Vice-Chairperson)
Gwen Black, PharmD
Marisa Wiktor, MD
January 2017 - December 2018 Term
Michelle Hilaire, PharmD
Andrew Davis, PharmD
James Feinstein, MD
Kimberley Jackson, DO
Scott Humphreys, MD
Steven Russell, MD
David Elwell, MD
If interested in serving or know someone who would be qualified, please submit a CV along with a completed Conflict of Interest form to:
Colorado Department of Health Care Policy and Financing Attn: Brittany Schock, PharmD 1570 Grant Street Denver, CO 80203
Or fax to 303-866-3590, Attn: Brittany Schock, PharmD.
Reasonable accommodations for the meetings will be provided upon request for persons with disabilities. Please contact the Program Administrator at least one week prior to the scheduled meeting if you need special arrangements.
